Adam M. Brufsky, MD, PhD | Authors


Adverse Effects of Anastrozole in Patients With DCIS

July 17, 2015

Adam M. Brufsky, MD, PhD, ​professor of medicine, University of Pittsburgh School of Medicine, associate director of clinical investigation, University of Pittsburgh Cancer Institute, discusses the adverse effects, as well as future treatments, of anastrozole in patients with ductal carcinoma In situ (DCIS).